Gould Capital’s Aehr Test Systems AEHR Stock Holding History

Gould Capital’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$96.1K	Hold	1,000	–	–	0.05%	73
2026 Q1	$37.1K	Hold	1,000	–	–	0.02%	94
2025 Q4	$20.2K	Hold	1,000	–	–	0.01%	121
2025 Q3	$30.1K	Hold	1,000	–	–	0.02%	103
2025 Q2	$12.9K	Buy	+1,000	New	+$9.52K	0.01%	131

Other funds holding AEHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Gould Capital's AEHR Position: Q2 2026 in Review

Gould Capital held its Aehr Test Systems (AEHR) position steady in Q2 2026 at 1,000 shares worth $96.1K. The position accounts for 0.05% of the portfolio, ranked #73.

Gould Capital first reported a position in AEHR in Q2 2025 and has held it in 5 quarters since. 262 funds tracked by Wall St. Rank hold AEHR as of Q2 2026.

Gould Capital held 1,000 shares of Aehr Test Systems worth $96.1K as of Q2 2026.
Gould Capital left its Aehr Test Systems share count unchanged in Q2 2026.
Aehr Test Systems made up 0.05% of Gould Capital's portfolio in Q2 2026, its #73 holding.
Gould Capital first reported a position in Aehr Test Systems in Q2 2025 and has held it in 5 quarters since.
262 funds tracked by Wall St. Rank held Aehr Test Systems as of Q2 2026.

Based on Gould Capital's 13F filing for Q2 2026, filed 7 Aug 2026.